← Reviews
Sep 2, 2026

Gut Dysbiosis, Serine-Glycine Metabolism, and Glioblastoma: Therapeutic Opportunities

A narrative review proposes that gut microbiota alterations modulate serine/glycine metabolism and may influence glioblastoma biology via the gut-brain axis.

Evidence levelDNarrative / animal / in vitro / mechanistic
Study typenarrative_review
Sample
Effect directionInsufficient
CertaintyVery low
Clinical applicabilityVery low
Overinterpretation risk1/5 · Low
PICO
Population
Intervention
Comparator
Outcome

What the study showed

The abstract outlines a biochemical framework linking gut dysbiosis to one-carbon metabolism and amino acid availability, affecting hepatic production of secondary metabolites such as taurine-conjugated bile acids. Authors position serine-glycine metabolism as a hub connecting microbiota, liver, and brain, with putative relevance to tumor growth, stemness, and therapy resistance in glioblastoma.

How it was done

This is a narrative review integrating existing literature on the gut-brain axis, amino acid metabolism, and glioblastoma biology, with no primary data collection or statistical analysis.

Risk of bias

Narrative reviews lack systematic selection criteria; the proposed causal links between dysbiosis, ser/gly metabolism, and glioblastoma progression in humans are not demonstrated, only hypothesized. The abstract does not report the scope or quality of included studies.

Interpretation limit

What this study does NOT prove

This review does not prove that microbiota-targeted or serine-glycine pathway interventions improve clinical outcomes in glioblastoma patients.

In clinical practice

No clinical recommendations can be derived. The proposed framework remains speculative and requires validation in prospective clinical studies.

Limitations

Narrative reviews lack systematic selection criteria; the proposed causal links between dysbiosis, ser/gly metabolism, and glioblastoma progression in humans are not demonstrated, only hypothesized. The abstract does not report the scope or quality of included studies.

Technical appendix

Version history

  • 1.0 · 2026-09-02 — Auto-generated under Evidence Standard v1.0

Paid access: structured summary from public metadata; consult the original study at the source.

Microbiota Weekly

The week in microbiota evidence, in your language. Structured summaries, traceable to the source.